Blue Jet Healthcare Ltd (BLUEJET) Q4FY26 Management Mirror - Mar-2026 Qtr
Contrast Media Segment
Management upgraded its growth outlook for the Contrast Media segment in the Mar'26 Qtr, projecting double-digit growth for FY27 driven by mid-single-digit growth from the flagship customer and three to four new product launches. Previously in the Sep'25 Qtr, the segment trend was viewed as stable. The commercial launch and volume ramp-up for the iodinated product, initially expected for commercial-scale production in Mar'26 (Sep'25 Qtr), is targeted for launch and immediate ramp-up starting Jun'26 (Dec'25 Qtr) and is currently undergoing validations alongside gadolinium products (Mar'26 Qtr). [Status: Upgraded]
3 more themes on the ELITE plan.